{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:23:54Z","timestamp":1789500234212,"version":"build-2803163510"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/aog.0b013e3181ec5fc1","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:23:22Z","timestamp":1282706602000},"page":"733-743","source":"Crossref","is-referenced-by-count":95,"title":["Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy"],"prefix":"10.1097","volume":"116","author":[{"given":"Jonathan S.","family":"Berek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Chalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210126","article-title":"Cancer facts and figures 2009.","year":"2009"},{"key":"R2-27-20210126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009.","volume":"59","author":"Jemal","year":"200","journal-title":"CA Cancer J Clin"},{"key":"R3-27-20210126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1525-1438.2001.01053.x","article-title":"The epidemiology of ovarian cancer.","volume":"11","author":"Edmondson","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"R4-27-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ijc.2910490110","article-title":"Pooled analysis of three European case\u2013control studies of epithelial ovarian cancer: I. Reproductive factors and risk of epithelial ovarian cancer.","volume":"49","author":"Negri","year":"1991","journal-title":"Int J Cancer"},{"key":"R5-27-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ijc.2910490111","article-title":"Pooled analysis of three European case\u2013control studies of epithelial ovarian cancer: II. Age at menarche and menopause.","volume":"49","author":"Franceschi","year":"1991","journal-title":"Int J Cancer"},{"key":"R6-27-20210126","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications [review].","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R7-27-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship.","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R8-27-20210126","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-27-20210126","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"R10-27-20210126","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact.","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"R11-27-20210126","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jnci\/djg010","article-title":"Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women.","volume":"95","author":"Engeland","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R12-27-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.","volume":"155","author":"Ness","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R13-27-20210126","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/gyno.2002.6746","article-title":"Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.","volume":"86","author":"Sit","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R14-27-20210126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer.","volume":"288","author":"Lacey","year":"2002","journal-title":"JAMA"},{"key":"R15-27-20210126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer.","volume":"302","author":"M\u00f8rch","year":"2009","journal-title":"JAMA"},{"key":"R16-27-20210126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutations carriers.","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R17-27-20210126","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4914(02)02434-6","article-title":"The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.","volume":"8","author":"Tutt","year":"2002","journal-title":"Trends Molecular Med"},{"key":"R18-27-20210126","first-page":"399","article-title":"Molecular genetics of hereditary ovarian cancer.","volume":"12","author":"Boyd","year":"1998","journal-title":"Oncology"},{"key":"R19-27-20210126","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R20-27-20210126","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R21-27-20210126","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-27-20210126","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"R23-27-20210126","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R24-27-20210126","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMed020044","article-title":"Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations.","volume":"346","author":"Haber","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-27-20210126","first-page":"434","article-title":"Decision analysis: effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 and BRCA2 mutations. N Engl J Med 1997;336:1465-71 erratum in N Engl J M","volume":"337","author":"Schrag","year":"1997","journal-title":"ed"},{"key":"R26-27-20210126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.2910490112","article-title":"Pooled analysis of three European case\u2013control studies of epithelial ovarian cancer: III. Oral contraceptive use.","volume":"49","author":"Franceschi","year":"1991","journal-title":"Int J Cancer"},{"key":"R27-27-20210126","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer.","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"R28-27-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contracep-tives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.","volume":"345","author":"Modan","year":"2001","journal-title":"N Engl J Med"},{"key":"R29-27-20210126","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"R30-27-20210126","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial.","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R31-27-20210126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian cancer: screening, treatment and follow-up.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R32-27-20210126","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bmj.306.6884.1025","article-title":"Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.","volume":"306","author":"Bourne","year":"1993","journal-title":"Br Med J"},{"key":"R33-27-20210126","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers: an observational follow-up study.","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"R34-27-20210126","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1471-0528.2007.01499.x","article-title":"Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.","volume":"114","author":"Woodward","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"R35-27-20210126","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1200\/JCO.2004.07.179","article-title":"Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.","volume":"22","author":"Hogg","year":"2004","journal-title":"J Clin Oncol"},{"key":"R36-27-20210126","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"Prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R37-27-20210126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000167394.38215.56","article-title":"Ovarian conservation at the time of hysterectomy for benign disease.","volume":"106","author":"Parker","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R38-27-20210126","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group.","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"R39-27-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pu.17.050196.000403","article-title":"Epidemiology and prevention of breast cancer.","volume":"17","author":"Kelsey","year":"1996","journal-title":"Annu Rev Public Health"},{"key":"R40-27-20210126","first-page":"890","article-title":"Compendium of Selected Publications. Prophylactic oophorectomy (original pub 1999).","year":"2007"},{"key":"R41-27-20210126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation.","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R42-27-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine papillary carcinoma.","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R43-27-20210126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment.","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R44-27-20210126","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajog.2008.08.045","article-title":"Oophorectomy as a risk for coronary heart disease.","volume":"200","author":"Jacoby","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R45-27-20210126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.fertnstert.2004.01.034","article-title":"Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause.","volume":"82","author":"Mack","year":"2004","journal-title":"Fertil Steril"},{"key":"R46-27-20210126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women.","volume":"316","author":"Colditz","year":"1987","journal-title":"N Engl J Med"},{"key":"R47-27-20210126","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/01.CIR.0000159344.21672.FD","article-title":"Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study.","volume":"111","author":"Howard","year":"2005","journal-title":"Circulation"},{"key":"R48-27-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2217\/17455057.5.1.39","article-title":"Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.","volume":"5","author":"Rocca","year":"2009","journal-title":"Women's Health (London Engl)"},{"key":"R49-27-20210126","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol"},{"key":"R50-27-20210126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause.","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"R52-27-20210126","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/gme.0b013e31816d5b1c","article-title":"Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study.","volume":"15","author":"Allison","year":"2008","journal-title":"Menopause"},{"key":"R53-27-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy.","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"key":"R54-27-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study.","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R55-27-20210126","first-page":"581","article-title":"Development of ovarian pathology after hysterectomy without oophorectomy.","volume":"178","author":"Plockinger","year":"1994","journal-title":"J Am Coll Surg"},{"key":"R56-27-20210126","first-page":"109","article-title":"Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study.","volume":"27","author":"Holub","year":"2000","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R57-27-20210126","first-page":"551","article-title":"The residual ovary syndrome.","volume":"46","author":"Christ","year":"1975","journal-title":"Obstet Gynecol"},{"key":"R58-27-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-2115(97)02702-4","article-title":"Is it necessary to perform a prophylactic oophorectomy during hysterectomy?","volume":"73","author":"Zalel","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R59-27-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0301-2115(96)00250-3","article-title":"The residual ovary syndrome: a 20-year experience.","volume":"68","author":"Dekel","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R60-27-20210126","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(16)57899-6","article-title":"Incidence of symptom recurrence after hysterectomy for endometriosis.","volume":"64","author":"Namnoum","year":"1995","journal-title":"Fertil Steril"},{"key":"R61-27-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejogrb.2009.05.007","article-title":"Repetitive surgery for recurrent symptomatic endometriosis: What to do?","volume":"146","author":"Vercellini","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R62-27-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","article-title":"Premature menopause or early menopause: long-term health consequences.","volume":"65","author":"Shuster","year":"2010","journal-title":"Maruritas"},{"key":"R63-27-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2005.07.110","article-title":"Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.","volume":"100","author":"Kotsopoulos","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R64-27-20210126","first-page":"1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopuase.","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R65-27-20210126","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1200\/JCO.2009.22.0764","article-title":"Use of hormone replacement therapy and the risk of colorectal cancer.","volume":"27","author":"Rennert","year":"2009","journal-title":"J Clin Oncol"},{"key":"R66-27-20210126","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement therapy for ovarian cancer survivors.","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"key":"R67-27-20210126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group study.","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"key":"R68-27-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped.","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"R69-27-20210126","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djk149","article-title":"Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol NO2C3.","volume":"99","author":"Barton","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R70-27-20210126","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.","volume":"16","author":"Loprinzi Cl, Pisansky","year":"1998","journal-title":"J Clin Oncol"},{"key":"R71-27-20210126","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.2009.24.5647","article-title":"Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.","volume":"28","author":"Loprinzi","year":"2010","journal-title":"J Clin Oncol"},{"key":"R72-27-20210126","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","article-title":"Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.","volume":"25","author":"Gnant","year":"2007","journal-title":"J Clin Oncol"},{"key":"R73-27-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201009000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:51Z","timestamp":1786041351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201009000-00027"}},"subtitle":["Recommendations Based on Risk of Ovarian Cancer"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181ec5fc1","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}